HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uyen Ngoc Mui Selected Research

Psoriatic Arthritis

1/2019Identification of Novel Autoantibodies Associated With Psoriatic Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uyen Ngoc Mui Research Topics

Disease

3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 01/2019
1Rosacea (Acne Rosacea)
01/2022
1Soft Tissue Infections
01/2022
1Skin Diseases (Skin Disease)
01/2022
1Acne Vulgaris
01/2022
1Hyperhidrosis
03/2019
1Psoriatic Arthritis
01/2019
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2019
1Disease Progression
01/2019
1Blister (Bulla)
01/2019
1Rheumatic Diseases (Rheumatism)
01/2019
1Cutaneous Mastocytosis
01/2019
1Benign Familial Pemphigus (Hailey Hailey Disease)
01/2018

Drug/Important Bio-Agent (IBA)

2Immunoglobulin G (IgG)IBA
01/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2019
2AntigensIBA
01/2020 - 01/2019
2AutoantibodiesIBA
01/2020 - 01/2019
2AutoantigensIBA
01/2020 - 01/2019
2CytokinesIBA
11/2019 - 01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1GliadinIBA
01/2020
1tildrakizumabIBA
11/2019
1Interleukin-12 (IL 12)IBA
11/2019
1Interleukin-23 (Interleukin 23)IBA
11/2019
1Interleukin-23 Subunit p19IBA
11/2019
1Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
03/2019
1SolutionsIBA
03/2019
1glycopyrronium tosylateIBA
03/2019
1diacereinIBA
01/2019
1Immunoglobulin E (IgE)IBA
01/2019
1Staphylococcal Protein A (Protein A)IBA
01/2019
1Omalizumab (Xolair)FDA Link
01/2019
1Ointments (Pastes)IBA
01/2019
1InterleukinsIBA
01/2019
1Calcineurin InhibitorsIBA
01/2018

Therapy/Procedure

2Therapeutics
01/2022 - 01/2019